Neurology and Neurosurgery - MedEd On The Go

Episodes 65-80 of 81

Patient Perspective: Living With Insomnia
Patient Perspective: Living With Insomnia
MinuteCE®
Patient Perspective: Living With Insomnia
0.75 program credits
- Kevin Trice, MD
0.75 program credits
Sleep Architecture and Neurotransmitters of Sleep
Sleep Architecture and Neurotransmitters of Sleep
MinuteCE®
Sleep Architecture and Neurotransmitters of Sleep
0.75 program credits
- Michael E. Yurcheshen, MD, FAASM
0.75 program credits
Exploring the Impact of Insomnia on Daytime Functioning and Cognition
Exploring the Impact of Insomnia on Daytime Functioning and Cognition
MinuteCE®
Exploring the Impact of Insomnia on Daytime Functioning and Cognition
0.75 program credits
- Michael E. Yurcheshen, MD, FAASM
- Kevin Trice, MD
0.75 program credits
Examining Treatment Options for Insomnia: From Orexin to GABA
Examining Treatment Options for Insomnia: From Orexin to GABA
MinuteCE®
Examining Treatment Options for Insomnia: From Orexin to GABA
0.75 program credits
- Kevin Trice, MD
0.75 program credits
Utilizing Assessment Tools in Insomnia
Utilizing Assessment Tools in Insomnia
MinuteCE®
Utilizing Assessment Tools in Insomnia
0.75 program credits
- Michael E. Yurcheshen, MD, FAASM
0.75 program credits
MinuteCE®
Insomnia Treatment Goals: Restful Nights and Productive Days
0.75 credits 6 episodes
- Kevin Trice, MD
- Michael E. Yurcheshen, MD, FAASM
0.75 credits 6 episodes
ANNEXa-I: Recent Advances in the Treatment of Intracranial Hemorrhage (ICH)
ANNEXa-I: Recent Advances in the Treatment of Intracranial Hemorrhage (ICH)
MinuteCE®
ANNEXa-I: Recent Advances in the Treatment of Intracranial Hemorrhage (ICH)
1.50 program credits
- Natalie Kreitzer, MD, MS
1.50 program credits
Pharmacy Perspectives: Real-World Management of Factor Xa Inhibitor Associated Bleeding Across 45 US Hospitals
Pharmacy Perspectives: Real-World Management of Factor Xa Inhibitor Associated Bleeding Across 45 US Hospitals
MinuteCE®
Pharmacy Perspectives: Real-World Management of Factor Xa Inhibitor Associated Bleeding Across 45 US Hospitals
1.50 program credits
- Paul P. Dobesh, PharmD, FACC, FAHA, FCCP, BCPS, BCCP
1.50 program credits
Clinical Implications of ANNEXa-I on the Management of ICH for Neurointensivists and Emergency Physicians
Clinical Implications of ANNEXa-I on the Management of ICH for Neurointensivists and Emergency Physicians
MinuteCE®
Clinical Implications of ANNEXa-I on the Management of ICH for Neurointensivists and Emergency Physicians
1.50 program credits
- W. Brian Gibler, MD, FACEP, FACC, FAHA
- Gregory J. Fermann, MD
- Natalie Kreitzer, MD, MS
- Paul P. Dobesh, PharmD, FACC, FAHA, FCCP, BCPS, BCCP
1.50 program credits
Life-Threatening Bleeding in the Anticoagulated Patient: Real World Evidence
Life-Threatening Bleeding in the Anticoagulated Patient: Real World Evidence
MinuteCE®
Life-Threatening Bleeding in the Anticoagulated Patient: Real World Evidence
1.50 program credits
- Natalie Kreitzer, MD, MS
1.50 program credits
Emergency Medicine Perspectives: Targeted vs. Nonspecific Approaches to Anticoagulation Reversal in Real World Analyses for ICH or GI Bleeds
Emergency Medicine Perspectives: Targeted vs. Nonspecific Approaches to Anticoagulation Reversal in Real World Analyses for ICH or GI Bleeds
MinuteCE®
Emergency Medicine Perspectives: Targeted vs. Nonspecific Approaches to Anticoagulation Reversal in Real World Analyses for ICH or GI Bleeds
1.50 program credits
- Gregory J. Fermann, MD
1.50 program credits
Andexanet Alfa Is Associated With Lower In-Hospital Mortality Compared to 4-Factor Prothrombin Complex Concentrate in Patients With Factor Xa Inhibitor–Related Major Bleeding
Andexanet Alfa Is Associated With Lower In-Hospital Mortality Compared to 4-Factor Prothrombin Complex Concentrate in Patients With Factor Xa Inhibitor–Related Major Bleeding
MinuteCE®
Andexanet Alfa Is Associated With Lower In-Hospital Mortality Compared to 4-Factor Prothrombin Complex Concentrate in Patients With Factor Xa Inhibitor–Related Major Bleeding
1.50 program credits
- Paul P. Dobesh, PharmD, FACC, FAHA, FCCP, BCPS, BCCP
1.50 program credits
Hematoma Expansion and Clinical Outcomes Comparison in ICH: Clinical Trial Results Versus Real World Care
Hematoma Expansion and Clinical Outcomes Comparison in ICH: Clinical Trial Results Versus Real World Care
MinuteCE®
Hematoma Expansion and Clinical Outcomes Comparison in ICH: Clinical Trial Results Versus Real World Care
1.50 program credits
- Natalie Kreitzer, MD, MS
1.50 program credits
Comparing In-hospital Mortality With Andexanet Alfa Versus 4-Factor Prothrombin Complex Concentrate
Comparing In-hospital Mortality With Andexanet Alfa Versus 4-Factor Prothrombin Complex Concentrate
MinuteCE®
Comparing In-hospital Mortality With Andexanet Alfa Versus 4-Factor Prothrombin Complex Concentrate
1.50 program credits
- Gregory J. Fermann, MD
1.50 program credits
MinuteCE®
The Life-Threatening Bleeding in the Anticoagulated Patient Journal Club: Real World Evidence for Effectiveness
1.50 credits 10 episodes
- W. Brian Gibler, MD, FACEP, FACC, FAHA
- Gregory J. Fermann, MD
- Paul P. Dobesh, PharmD, FACC, FAHA, FCCP, BCPS, BCCP
- Natalie Kreitzer, MD, MS
1.50 credits 10 episodes
GI Bleeding and DOACs: Consensus Panel Findings
GI Bleeding and DOACs: Consensus Panel Findings
MinuteCE®
GI Bleeding and DOACs: Consensus Panel Findings
1.50 program credits
- Gregory J. Fermann, MD
1.50 program credits

5/6